Arch Oncology Inc.

The flow of venture capital into biopharmaceutical companies has been astonishing – breaking the prior record by a wide margin in 2020 – and, so far, 2021 looks like it is on track to leave a big gap

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmace